Request Deal Involvement

NEA, Abingworth and Forge Life led a $120m Series C round in Escient Pharmaceuticals.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Principals

ESCIENT PHARMACEUTICALS

target

ESCIENT PHARMACEUTICALS

ABINGWORTH MANAGEMENT

bidder

ABINGWORTH MANAGEMENT

FORGE LIFE SCIENCE PARTNERS

bidder

FORGE LIFE SCIENCE PARTNERS

AVEGO MANAGEMENT

bidder

AVEGO MANAGEMENT

PFM HEALTH SCIENCES

bidder

PFM HEALTH SCIENCES

THE ELEVEN FUND

bidder

THE ELEVEN FUND

THE COLUMN GROUP

bidder

THE COLUMN GROUP

5AM VENTURES LLC

bidder

5AM VENTURES LLC

REDMILE GROUP

bidder

REDMILE GROUP

BLUE OWL HEALTHCARE OPPORTUNITIES (EX-COWEN HEALTHCARE INVESTMENTS)

bidder

BLUE OWL HEALTHCARE OPPORTUNITIES (EX-COWEN HEALTHCARE INVESTMENTS)

SANOFI VENTURES

bidder

SANOFI VENTURES

OSAGE UNIVERSITY PARTNERS

bidder

OSAGE UNIVERSITY PARTNERS

ALTITUDE LIFE SCIENCE VENTURES

bidder

ALTITUDE LIFE SCIENCE VENTURES

NEW ENTERPRISE ASSOCIATES (NEA)

bidder

NEW ENTERPRISE ASSOCIATES (NEA)

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - NEA, Abingworth and Forge Life led a $120m Series C round in Escient Pharmaceuticals.